Press Releases on February 20, 2025 - EIN Presswire - Press Release Distribution Service

Published on February 20, 2025 - 21:05 GMT

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 20, 2025 - 21:05 GMT

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

SILVER SPRING, Md., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its fourth quarter and full year 2024 financial results …

Distribution channels:

Published on February 20, 2025 - 21:05 GMT

LPL Financial Reports Monthly Activity for January 2025

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC (“LPL Financial”), a wholly owned subsidiary of LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), today released its monthly activity report for January 2025. Total advisory and …

Distribution channels: Business & Economy ...

Published on February 20, 2025 - 21:05 GMT

CarGurus Announces Fourth Quarter and Full Year 2024 Results

Q4’24 Marketplace revenue grew 15% YoY Q4’24 International revenue grew 26% YoY and OEM Advertising revenue grew double-digit YoY Q4'24 Consolidated GAAP Net Income of $45.9 million; Q4'24 Non-GAAP Consolidated Adjusted EBITDA of $76.4 million, up …

Distribution channels: Business & Economy, IT Industry ...

Published on February 20, 2025 - 21:05 GMT

Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in two upcoming investment bank conferences. The TD Cowen 45th Annual Healthcare Conference is being held …

Distribution channels:

Published on February 20, 2025 - 21:05 GMT

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

SAN FRANCISCO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the …

Distribution channels:

Published on February 20, 2025 - 21:05 GMT

Hydrofarm Holdings Group, Inc. to Announce Fourth Quarter and Full Year 2024 Results on March 5, 2025

SHOEMAKERSVILLE, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled …

Distribution channels: Culture, Society & Lifestyle, Electronics Industry ...

Published on February 20, 2025 - 21:05 GMT

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

MOUNTAIN VIEW, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it has completed the previously announced plan to repurchase …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 20, 2025 - 21:05 GMT

Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that it will hold a conference call …

Distribution channels:

Published on February 20, 2025 - 21:05 GMT

JAKKS Pacific Reports Fourth Quarter and Full-Year 2024 Financial Results

SANTA MONICA, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (Nasdaq: JAKK) today reported financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Net sales were $130.7 million, a year-over-year …

Distribution channels:

Published on February 20, 2025 - 21:05 GMT

Y-mAbs to Announce Fourth Quarter and Full Year 2024 Financial and Operating Results on March 4, 2025

NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 20, 2025 - 21:05 GMT

Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, …

Distribution channels:

Published on February 20, 2025 - 21:05 GMT

CTO Realty Growth Reports Fourth Quarter and Full Year 2024 Operating Results

– Closed investments of $330.8 million at a weighted average initial cash yield 9.3% in 2024 – – Raised $165.2 million of net proceeds under common ATM program in 2024 – – Current signed-not-open pipeline of $5.2 million – WINTER PARK, Fla., Feb. 20, 2025 …

Distribution channels: Business & Economy, Real Estate & Property Management ...

Published on February 20, 2025 - 21:05 GMT

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

FOSTER CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 20, 2025 - 21:05 GMT

Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders

BALTIMORE, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to EXG …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on February 20, 2025 - 21:05 GMT

Altair Announces Fourth Quarter and Full Year 2024 Financial Results

TROY, Mich., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Altair (Nasdaq: ALTR), a global leader in computational intelligence, today released its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights …

Distribution channels:

Published on February 20, 2025 - 21:05 GMT

Former Interior Secretary David Bernhardt Joins Trump Media Board of Directors

Bernhardt to Replace Newly Confirmed FBI Director Kash Patel SARASOTA, Fla., Feb. 20, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Trump Media and Technology Group Corp. (Nasdaq: DJT) ("TMTG"), operator of the social media platform Truth …

Distribution channels: Companies, Media, Advertising & PR ...

Published on February 20, 2025 - 21:05 GMT

Vicor Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2024

ANDOVER, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ: VICR) today reported financial results for the fourth quarter and year ended December 31, 2024. These results will be discussed later today at 5:00 p.m. Eastern Time, during …

Distribution channels: Business & Economy, Energy Industry ...

Published on February 20, 2025 - 21:05 GMT

Century Aluminum Company Reports Fourth Quarter 2024 Results

CHICAGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its fourth quarter and full year 2024 results. Fourth Quarter 2024 Highlights Net sales $631.0 million Reported net income attributable to Century …

Distribution channels: Business & Economy, Media, Advertising & PR ...

Published on February 20, 2025 - 21:04 GMT

Study Examines the Age of Groundwater and Nitrate Trends in Southeast Minnesota

A newly published study by researchers at the Minnesota Department of Agriculture (MDA), the University of Minnesota’s Minnesota Geological Survey, and the Minnesota Department of Natural Resources reveals new information about the age of groundwater in …

Distribution channels: